Literature DB >> 20056331

Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis.

Ana M Espino1, Francheska Rivera.   

Abstract

Use of the rabbit as disease model has long been hampered by a lack of immunological assays specific to this species. In the present study we developed a SYBR Green-based, real-time RT-PCR protocol to quantitate cytokine mRNA in freshly harvested rabbit peripheral mononuclear cells. The method was validated in the course of a vaccination trial in which animals vaccinated with the recombinant antigen FhSAP2 were challenged with Fasciola hepatica metacercariae. Changes in the levels of rabbit interleukin (IL)-2, IL-4, IL-6, IL-10, tumor necrosis factor-alpha (TNFalpha), and interferon-gamma (IFNgamma) mRNA were determined. Messenger RNA from the universally expressed housekeeping gene GAPDH was used as an amplification control and allowed for correction of variations in the efficiencies of RNA extraction and reverse transcription. Rabbits vaccinated with FhSAP2 showed an 83.3% reduction in liver fluke burden after challenge infection when compared to non-vaccinated controls. All cytokine mRNAs were found at detectable levels; however, the levels of IFNgamma, TNFalpha, IL-2 and IL-10 were significantly higher in the vaccinated group compared to the non-vaccinated group. These results suggest that protection conferred by FhSAP2 protein could be associated with a mixed Th1/Th2 immune response in which Th1 cytokines are dominant. The real-time RT-PCR method described herein can be a useful tool for monitoring changes in basic immune functions in the rabbit model of fascioliasis and may also aid in studies of human diseases for which the rabbit is an important experimental model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20056331      PMCID: PMC3260557          DOI: 10.1016/j.vetpar.2009.12.018

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  68 in total

1.  The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells.

Authors:  Bruce S Thompson; Paula M Chilton; Jon R Ward; Jay T Evans; Thomas C Mitchell
Journal:  J Leukoc Biol       Date:  2005-10-04       Impact factor: 4.962

2.  Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes.

Authors:  Kenneth E Palmer; Ann Benko; Sarah A Doucette; Terri I Cameron; Tiffany Foster; Kathleen M Hanley; Alison A McCormick; Michael McCulloch; Gregory P Pogue; Mark L Smith; Neil D Christensen
Journal:  Vaccine       Date:  2006-05-06       Impact factor: 3.641

3.  A study of the liver of goats immunized with a synthetic peptide of the Sm14 antigen and challenged with Fasciola hepatica.

Authors:  R Zafra; L Buffoni; A Martínez-Moreno; A Pérez-Ecija; F J Martinez-Moreno; J Pérez
Journal:  J Comp Pathol       Date:  2008-09-03       Impact factor: 1.311

Review 4.  Cytokines and the mechanisms of action of vaccine adjuvants.

Authors:  J M Brewer; J Alexander
Journal:  Cytokines Cell Mol Ther       Date:  1997-12

5.  Th1/Th2 biasing effects of vaccination in cattle as determined by real-time PCR.

Authors:  Angelo Mena; Xenia P Ioannou; Andrew Van Kessel; Sylvia Van Drunen Little-Van Den Hurk; Yurij Popowych; Lorne A Babiuk; Dale L Godson
Journal:  J Immunol Methods       Date:  2002-05-01       Impact factor: 2.303

6.  CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase.

Authors:  O Silvennoinen; H Nishigaki; A Kitanaka; M Kumagai; C Ito; F Malavasi; Q Lin; M E Conley; D Campana
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

7.  IL-12 induces human T cells secreting IL-10 with IFN-gamma.

Authors:  A Windhagen; D E Anderson; A Carrizosa; R E Williams; D A Hafler
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

8.  Gene expression profiling of chicken lymphoid cells after treatment with Lactobacillus acidophilus cellular components.

Authors:  Jennifer T Brisbin; Huaijun Zhou; Joshua Gong; Parviz Sabour; Mohammad Reza Akbari; Hamid Reza Haghighi; Hai Yu; Anthony Clarke; Aimie Jey Sarson; Shayan Sharif
Journal:  Dev Comp Immunol       Date:  2007-10-16       Impact factor: 3.636

9.  Experimental infections with Fasciola in snails, mice and rabbits.

Authors:  Abdel-Nasser A Hussein; R M A Khalifa
Journal:  Parasitol Res       Date:  2008-02-02       Impact factor: 2.289

10.  Influence of anti-inflammatory treatments on experimental infection of rats with Fasciola hepatica: changes in serum levels of inflammatory markers during the early stages of fasciolosis.

Authors:  E Baeza; I Poitou; F Delers; C Boulard
Journal:  Res Vet Sci       Date:  1994-09       Impact factor: 2.534

View more
  14 in total

1.  Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis.

Authors:  Olgary Figueroa-Santiago; Bonnibel Delgado; Ana M Espino
Journal:  Diagn Microbiol Infect Dis       Date:  2011-07       Impact factor: 2.803

2.  PEDF plus DHA modulate inflammation and stimulate nerve regeneration after HSV-1 infection.

Authors:  Jiucheng He; Donna Neumann; Azucena Kakazu; Thang Luong Pham; Farhana Musarrat; M Soledad Cortina; Haydee E P Bazan
Journal:  Exp Eye Res       Date:  2017-06-20       Impact factor: 3.467

3.  Cell-free expression, purification and immunoreactivity assessment of recombinant Fasciola hepatica saposin-like protein-2.

Authors:  Marcos J Ramos-Benítez; Luis M Lopez-Cruz; Vasti Aguayo; Caleb Ruiz-Jimenez; Ana M Espino
Journal:  Mol Biol Rep       Date:  2018-07-21       Impact factor: 2.316

4.  Differential expression and localization of saposin-like protein 2 of Fasciola hepatica.

Authors:  Kimberly Cabán-Hernández; Ana M Espino
Journal:  Acta Trop       Date:  2013-08-26       Impact factor: 3.112

5.  Fasciola hepatica ESPs Could Indistinctly Activate or Block Multiple Toll-Like Receptors in a Human Monocyte Cell Line.

Authors:  Olgary Figueroa-Santiago; Ana M Espino
Journal:  Ann Clin Pathol       Date:  2017-03-31

6.  Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica.

Authors:  Francheska Rivera; Ana M Espino
Journal:  Exp Parasitol       Date:  2015-11-26       Impact factor: 2.011

Review 7.  Recent Developments in Recombinant Proteins for Diagnosis of Human Fascioliasis.

Authors:  Abolfazl Mirzadeh; Farid Jafarihaghighi; Elham Kazemirad; Shokouh Shahrokhi Sabzevar; Mohammad Hossein Tanipour; Mehdi Ardjmand
Journal:  Acta Parasitol       Date:  2020-09-24       Impact factor: 1.440

8.  Development and validation of a harmonized TaqMan-based triplex real-time RT-PCR protocol for the quantitative detection of normalized gene expression profiles of seven porcine cytokines.

Authors:  Anja Petrov; Martin Beer; Sandra Blome
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

9.  In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes.

Authors:  Jose Rojas-Caraballo; Julio López-Abán; Luis Pérez del Villar; Carolina Vizcaíno; Belén Vicente; Pedro Fernández-Soto; Esther del Olmo; Manuel Alfonso Patarroyo; Antonio Muro
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

10.  Molecular characterization and analysis of TLR-1 in rabbit tissues.

Authors:  Wael M K Elfeil; Abdelazeem M Algammal; Reham R Abouelmaatti; Ahmed Gerdouh; Mohamed Abdeldaim
Journal:  Cent Eur J Immunol       Date:  2016-10-25       Impact factor: 2.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.